Liminatus Pharma, Inc. Class A Common Stock
LIMN •
Sell Open
Signal type
Sell
Status
Open
Open Price
$0.19
Stop Loss
$2.16
Performance
6.55%
Days Open
27
Signal Setup
Signal Type Sell
Status Open
Open Date Mar 19, 2026
Open Price $0.19
Stop Loss $2.16
Timespan Day
Company Profile
Name Liminatus Pharma, Inc. Class A Common Stock
Ticker LIMN
Market Cap $180.28M
Sector BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Latest Close $0.18
List Date May 1, 2025
Description
Liminatus Pharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing cancer therapies and treatments. The GCC Vaccine of the company is in Phase II of clinical trials designed for immune behavior towards colorectal, pancreatic, gastric, and esophageal cancers that express Guanylyl Cyclase C.
Website Open Company Website